These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6891751)
1. Effects of beta-/Tyr9/melanotropin-/9-18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine. Vécsei L; Telegdy G; Schally AV; Coy DH Neuropeptides; 1982 Dec; 3(2):91-6. PubMed ID: 6891751 [TBL] [Abstract][Full Text] [Related]
2. Comparative studies with beta-(Tyr9)melanotropin-(9-18) and amphetamine on open-field behavior and striatal dopamine uptake and release. Vécsei L; Bollók I; Telegdy G; Schally AV Pharmacol Res Commun; 1984 Jul; 16(7):689-97. PubMed ID: 6473485 [TBL] [Abstract][Full Text] [Related]
3. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice. Kovács GL; Szabó G; Penke B; Telegdy G Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512 [TBL] [Abstract][Full Text] [Related]
4. The interaction between beta-[Tyr9]melanotropin-(9-18), haloperidol and amphetamine in different behavior tests of rats. Telegdy G; Vécsei L; Schally AV; Coy DH Pharmacol Biochem Behav; 1982 Jul; 17(1):15-8. PubMed ID: 7122660 [TBL] [Abstract][Full Text] [Related]
5. Effect of intracisternally administered adenosine and inosine on apomorphine- and amphetamine-induced stereotyped behaviour in rats. Singh J Indian J Physiol Pharmacol; 1990 Jan; 34(1):45-7. PubMed ID: 2361724 [No Abstract] [Full Text] [Related]
6. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Protais P; Costentin J; Schwartz JC Psychopharmacology (Berl); 1976 Oct; 50(1):1-6. PubMed ID: 827755 [TBL] [Abstract][Full Text] [Related]
7. Effect of intracerebroventricular administration of beta-/Tyr9/-melanotropin-/9-18/ on rotational behavior induced by substantia nigra lesion in rats. Vécsei L; Bollók I; Telegdy G; Coy DH; Schally AV Neuropeptides; 1983 Oct; 3(6):435-42. PubMed ID: 6664471 [TBL] [Abstract][Full Text] [Related]
8. Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates. Kuczenski R; Segal DS; Manley LD J Neurochem; 1990 May; 54(5):1492-9. PubMed ID: 2324735 [TBL] [Abstract][Full Text] [Related]
9. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy. Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236 [TBL] [Abstract][Full Text] [Related]
10. Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice. Randall PK; Severson JA; Hurd SM; McClure WO Brain Res; 1985 Apr; 333(1):85-95. PubMed ID: 4039618 [TBL] [Abstract][Full Text] [Related]
11. Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function. Jerussi TP; Glick SD Psychopharmacology (Berl); 1976 Jun; 47(3):249-60. PubMed ID: 823560 [TBL] [Abstract][Full Text] [Related]
12. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine. Agut J; Coviella IL; Wurtman RJ Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245 [TBL] [Abstract][Full Text] [Related]
13. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617 [TBL] [Abstract][Full Text] [Related]
14. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255 [TBL] [Abstract][Full Text] [Related]
15. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone. Conway P; Uretsky NJ Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493 [TBL] [Abstract][Full Text] [Related]
16. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra. Price MT; Fibiger HC Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562 [No Abstract] [Full Text] [Related]
17. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment. Kuczenski R; Leith NJ; Applegate CD Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917 [TBL] [Abstract][Full Text] [Related]